Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Savi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|February 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient MonitoringAlessandro Ferrando, Valentina Bonuomo, Arianna Savi, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Cancers|November 13, 2025
The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted TherapeuticsValentina Bonuomo, Irene Dogliotti, Simona Masucci, et al.
Expert Review of Molecular Diagnostics|November 12, 2019
Applications and efficiency of flow cytometry for leukemia diagnosticsMaria Ilaria Del Principe, Eleonora De Bellis, Carmelo Gurnari, et al.
Frontiers in Oncology|May 2, 2022
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisLuca Guarnera, Tiziana Ottone, Emiliano Fabiani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.
International Journal of Molecular Sciences|February 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AMLElisa Meddi, Arianna Savi, Federico Moretti, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Frontiers in Oncology|October 3, 2022
Case report: A <i>Saprochaete clavata</i> (<i>Magnusiomyces clavatus</i>) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcomaGianmario Pasqualone, Elisa Buzzatti, Raffaele Palmieri, et al.
Journal of Translational Medicine|July 6, 2022
Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD-positive acute myeloid leukemiaGabriele Lo Iudice, Eleonora De Bellis, Arianna Savi, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|February 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient MonitoringAlessandro Ferrando, Valentina Bonuomo, Arianna Savi, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Cancers|November 13, 2025
The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted TherapeuticsValentina Bonuomo, Irene Dogliotti, Simona Masucci, et al.
Expert Review of Molecular Diagnostics|November 12, 2019
Applications and efficiency of flow cytometry for leukemia diagnosticsMaria Ilaria Del Principe, Eleonora De Bellis, Carmelo Gurnari, et al.
Frontiers in Oncology|May 2, 2022
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisLuca Guarnera, Tiziana Ottone, Emiliano Fabiani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, et al.
International Journal of Molecular Sciences|February 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AMLElisa Meddi, Arianna Savi, Federico Moretti, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Frontiers in Oncology|October 3, 2022
Case report: A <i>Saprochaete clavata</i> (<i>Magnusiomyces clavatus</i>) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcomaGianmario Pasqualone, Elisa Buzzatti, Raffaele Palmieri, et al.
Journal of Translational Medicine|July 6, 2022
Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD-positive acute myeloid leukemiaGabriele Lo Iudice, Eleonora De Bellis, Arianna Savi, et al.
Pageof 2